Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Use this CAPR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CAPR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CAPR SEC filings page. Lician reads the product cache first so this HTML stays unique to Capricor Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full CAPR income, balance, and cash tables.